Population Pharmacokinetics and its Role in Anti-Tuberculosis Drug Development and Optimization of Treatment

E-ISSN： 1873-4286|17|27|2889-2899

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.27, 2011-09, pp. : 2889-2899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Population Pharmacokinetics in Drug Development in Light of the Food and Drug Administration's Guidance for Industry: Population Pharmacokinetics

By Williams P.J.

Clinical Pharmacokinetics, Vol. 39, Iss. 6, 2000-12 ,pp. : 385-395

Adis International

Access to resources Recommend Favorite

Computational Biology in Anti-Tuberculosis Drug Discovery

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 319-326

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs in Clinical Development: An Overview

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 105-105

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 53-53

Bentham Science Publishers

Access to resources Recommend Favorite